top of page

Important Safety Information for 
Methylene Blue Legal & Safety Compliance Disclosure

The information provided below constitutes critical medical safety parameters, regulatory disclosures, and compliance guidelines for the use of pharmaceutical-grade Methylene Blue. This page serves to ensure consumer safety, adverse event prevention, and full transparency regarding the contraindications associated with this compound.

​

1. High-Risk Medical Contraindications

​

Due to specific biochemical interactions, Methylene Blue is strictly contraindicated for individuals with the following medical profiles. Ingestion under these conditions poses severe, life-threatening health risks:

​

  • Concomitant Serotonergic Medication Use (Risk of Serotonin Syndrome): Methylene Blue exhibits potent monoamine oxidase inhibitor (MAOI) properties. It must never be co-administered with Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs), MAOIs, or certain opioid analgesics (e.g., tramadol). Concomitant use can cause Serotonin Syndrome, a critical medical emergency characterized by neuromuscular hyperactivity, autonomic instability, altered mental status, and hyperthermia.

​

  • Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: Individuals with an inherited G6PD enzyme deficiency must absolutely avoid Methylene Blue. Administration can induce severe, acute hemolytic anemia (the rapid destruction of red blood cells), leading to profound tissue hypoxia and renal stress.

​

  • Pregnancy, Gestational Plans, and Lactation: Methylene Blue is a known teratogen and can cause direct fetal harm or complications during gestation. It is strictly contraindicated for individuals who are pregnant, planning to become pregnant, or actively breastfeeding.

2. Mandatory Disclaimers & FDA Compliance

​

FDA Regulation Status: Statements regarding the dietary, metabolic, or cellular benefits of Methylene Blue have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease or chronic medical condition.

​

  • Independent Medical Advice: The content on this website, including all safety data, is provided solely for informational and educational purposes. It does not substitute for professional medical advice, diagnosis, or clinical treatment.

  • Physician Clearance: Consumers are legally advised and structurally required to consult a qualified healthcare provider prior to initiating any new metabolic protocol, particularly individuals with pre-existing hepatic (liver) or renal (kidney) impairments.

 

3. Expected Physiological Changes (Non-Adverse Reactions)

​

For transparency and to prevent unnecessary medical concern, consumers must be aware of the following benign physiological responses:

​

  • Chromaturia: Methylene Blue is excreted primarily via the renal system. Temporary blue, green, or teal discoloration of the urine and stool is a medically harmless, expected result of the compound's pigment clearance.

  • Gustatory Changes: A temporary metallic or bitter taste may manifest post-ingestion.

 

4. Quality & Purity Compliance Standards

 

We strictly dispense USP Pharmaceutical-Grade Methylene Blue (>99% purity). Industrial, chemical, or aquarium-grade alternatives contain heavy metals (such as arsenic, lead, and mercury) and are strictly unfit for human consumption.

bottom of page